Showing results (211-220 of 399) with videos related to

Sort By:
Pageof 40
Cancer|May 13, 2016
Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemiaAmir T Fathi, Daniel J DeAngelo, Kristen E Stevenson, et al.
The Journal of Experimental Medicine|December 12, 2007
Alu elements mediate MYB gene tandem duplication in human T-ALLJennifer O'Neil, Joelle Tchinda, Alejandro Gutierrez, et al.
Leukemia|July 17, 2026
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemiaMax S Topp, Bijal D Shah, Elias Jabbour, et al.
Nature Communications|August 25, 2022
Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1Hsiao-Yun Chen, Yavuz T Durmaz, Yixiang Li, et al.
Cell Reports|March 5, 2013
Structure and ubiquitination-dependent activation of TANK-binding kinase 1Daqi Tu, Zehua Zhu, Alicia Y Zhou, et al.
Blood|April 26, 2014
Requirement for CDK6 in MLL-rearranged acute myeloid leukemiaTheresa Placke, Katrin Faber, Atsushi Nonami, et al.
JCO Precision Oncology|October 5, 2020
Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement AnalysisYi Lee, Evan W Clark, Marina S D Milan, et al.
Blood|July 27, 2018
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AMLAmir T Fathi, Harry P Erba, Jeffrey E Lancet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2013
A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targetsSophia Adamia, Benjamin Haibe-Kains, Patrick M Pilarski, et al.
NEJM Evidence|July 24, 2023
Prediction of risk for myeloid malignancy in clonal hematopoiesisLachelle D Weeks, Abhishek Niroula, Donna Neuberg, et al.
Pageof 40